Payer Marketing - pharmaLevers

Go to content

Payer Marketing


Additional clinical benefit is the key value message of manufacturers. Payers often have a different definition and perception of clinical value. In addition payers are gaining influence on both decision makers and providers. This may lead to a delay of market access and market uptake.

Access to and communication with payers is crucial. However, there are barriers!

pharmaLevers is helping clients to overcome these barriers by:

  • facilitating access to payers

  • delivering payer insights

  • delivering messages that are addressing payers key concerns directly

  • design and implement new ways to marketing drugs to payers  

Swiss Payer Study (click):
Are the pricing models and managed entry agreements (MES) used for the twenty best-selling drugs of 2019 sustainable and expedient for the Swiss healthcare system? What further optimizations would be necessary to dampen the cost development?

Photo: © mybaitshop/
Back to content